Compare HALO & CWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HALO | CWST |
|---|---|---|
| Founded | 1998 | 1975 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Environmental Services |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 6.4B |
| IPO Year | 2001 | 1997 |
| Metric | HALO | CWST |
|---|---|---|
| Price | $110.30 | $93.49 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 7 |
| Target Price | $78.64 | ★ $115.71 |
| AVG Volume (30 Days) | ★ 2.2M | 409.6K |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.11 | N/A |
| Revenue | $151,862,000.00 | ★ $1,836,841,000.00 |
| Revenue This Year | $28.24 | $10.95 |
| Revenue Next Year | $12.56 | $6.97 |
| P/E Ratio | $35.43 | ★ N/A |
| Revenue Growth | N/A | ★ 17.95 |
| 52 Week Low | $61.23 | $74.05 |
| 52 Week High | $111.15 | $107.96 |
| Indicator | HALO | CWST |
|---|---|---|
| Relative Strength Index (RSI) | 73.97 | 59.98 |
| Support Level | $67.12 | $92.63 |
| Resistance Level | N/A | $98.79 |
| Average True Range (ATR) | 2.70 | 2.42 |
| MACD | -0.52 | 0.27 |
| Stochastic Oscillator | 92.44 | 96.26 |
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.
Casella Waste Systems Inc is a solid waste removal company, providing resource management services to residential, commercial, municipal, and industrial customers. The company's reportable segments on Geographical basis include Eastern, Western and Mid-Atlantic regions through the Resource solution segment. It generates maximum revenue from the Western region segment. The company's services include Recycling, Collection, Organics, Energy, Landfills, Special Waste as well as Professional Services.